Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no clinically mandated time of day to take Mounjaro. The injection is licensed as a once-weekly dose and the prescribing information does not specify morning or night — you can take it at whatever point in the week suits your routine, provided you keep the day consistent. That said, many people find that the timing they choose shapes how noticeable any side effects feel, and that practical question is worth thinking through carefully. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception circulating in weight-loss forums is that injecting in the morning somehow boosts results, or that evening injections accelerate fat burning overnight. Neither claim holds up. Tirzepatide has a half-life of approximately five days, which means it accumulates gradually in the body and maintains a near-steady concentration between doses. The pharmacology doesn't shift meaningfully based on whether you inject at 7am or 10pm. What matters far more is that you inject once a week, on the same day, not the hour on the clock. The tirzepatide overview on our site explains how the dual GIP and GLP-1 receptor mechanism works, and none of it depends on circadian timing.
This matters because chasing an 'optimal' hour can introduce a different risk: inconsistency. Someone who tries morning one week, switches to evening the next because they read a contradictory post, then forgets entirely because the anchor-habit never formed, that person is more likely to miss doses. Missed doses are the actual problem to avoid, not the hour of the day.
Preference for evening injections is not folklore. There is a sensible practical rationale: the most commonly reported side effects of Mounjaro are gastrointestinal (nausea, indigestion, occasional vomiting) and they tend to peak in the hours after injection, particularly in the early weeks or after stepping up a dose. Injecting before bed means a large chunk of that window passes during sleep, when the discomfort is simply less noticeable. Some people report waking feeling slightly queasy but find it settles quickly with breakfast; others find they sleep through it entirely. If nausea has been your main concern, it is a reasonable approach to discuss with your prescriber. The question of night versus morning is one our clinical team fields regularly.
There is no published clinical trial showing that evening dosing reduces side-effect severity in a statistically significant way, so this is practical preference, not a clinical instruction. The NHS patient information for tirzepatide, available on the NHS medicines page for tirzepatide, confirms that the injection can be taken at any time of day.
Morning injection suits people who prefer to attach new habits to the start of the day: pen out of the fridge, rotation site clean, done before coffee. The routine is visible and harder to forget. It also ties in neatly with the weekly-day consistency rule, Monday mornings, say, become a reliable anchor. If you already take other medicines in the morning, your prescriber can advise on spacing. One specific point worth flagging: women taking oral contraceptives alongside tirzepatide are advised to use an additional non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because gastric slowing may reduce how well the pill is absorbed. The interaction between Mounjaro and hormonal contraception is covered in more detail elsewhere on our site. Transdermal methods (patches, rings) are not subject to the same concern.
For anyone weighing up costs alongside timing questions, the Mounjaro cost page gives honest context on private treatment pricing in the UK.
Pick a time you can sustain for weeks on end. That is the only real test. If you travel for work and Tuesday evenings are chaotic, Tuesday mornings are better. If you have young children and mornings are already fractured, an after-dinner Sunday injection might stick more reliably. Once you have chosen, try not to shift it. Altering the day occasionally is permissible (the SmPC guidance allows a window of flexibility) but regularly switching between morning and night undermines the consistency that keeps the habit solid.
When your pen arrives via DPD in plain, unbranded packaging, the outer box goes straight to the fridge. The KwikPen itself should be removed and allowed to reach room temperature before use, and if you are still working out whether morning or evening suits you better, building the warm-up step into whichever slot you choose is a good way to reinforce the habit. Anyone struggling with how treatment is going (timing included) can reach our aftercare team seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.